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OBJECTIVES: The aim of this study was to investigate neuropsychological performance and biomarkers of
oxidative stress in patients with obstructive sleep apnea and the relationships between these factors.
METHODS: This was an observational, cross-sectional study of 14 patients (36.0¡6.5 years old) with obstructive
sleep apnea and 13 controls (37.3¡6.9 years old). All of the participants were clinically evaluated and
underwent full-night polysomnography as well as neuropsychological tests. Blood samples were used to assay
superoxide dismutase, catalase, glutathione and homocysteine, as well as vitamins E, C, B11 and B12.
RESULTS: The patients performed poorly relative to the controls on several neuropsychological tests, such as the
attention test and tests of long-term memory and working memory/executive function. They also had lower
levels of vitamin E (p,0.006), superoxide dismutase (p,0.001) and vitamin B11 (p,0.001), as well as higher
concentrations of homocysteine (p,0.02). Serum concentrations of vitamin C, catalase, glutathione and vitamin
B12 were unaltered. Vitamin E levels were related to performance in the backward digit span task (F = 15.9;
p=0.002) and this correlation remained after controlling for age and body mass index (F = 6.3, p=0.01). A
relationship between superoxide dismutase concentrations and executive non-perseveration errors in the
Wisconsin Card Sorting Test (F = 7.9; p=0.01) was also observed.
CONCLUSIONS: Decreased levels of antioxidants and lower performance on the neuropsychological tasks were
observed in patients with obstructive sleep apnea. This study suggests that an imbalance between antioxidants
and pro-oxidants may contribute to neuropsychological alterations in this patient population.
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& INTRODUCTION
Obstructive sleep apnea (OSA) is characterized by re-
current episodes of either total or partial obstruction of
the upper airway during sleep, which leads to intermittent
hypoxemia, transitory hypercapnia and frequent arousals
(1). In addition to cardiovascular morbidity, OSA is
associated with a wide spectrum of cognitive symptoms,
from mild attention deficits to severe daytime sleepiness
(2,3). Several studies have confirmed the presence of
neuropsychological alterations in OSA patients (4-6). OSA
has a profound impact on psychomotor functioning and
cognitive domains, such as attention, memory and executive
functioning (7). A decline has been reported in particular
cognitive domains, such as attention, long-term episodic
memory and working memory/executive function (8-11).
Given the complexity of this subject and the potential
interactions, a multi-compartment model of working memory
has been proposed (12,13). Although intermittent hypoxemia
and frequent arousals, either individually or in combination,
are involved in these cognitive alterations, the pathophysiol-
ogy of the neuropsychological deficits has not yet been
completely determined (14,15).
The relationship between cognitive dysfunction and
oxidative stress has not been extensively investigated,
although higher levels of oxidative stress biomarkers have
been linked to increased cardiovascular morbidity in OSA
individuals (16). However, controversy remains regarding
the best marker of oxidative stress. High levels of certain
biomarkers, including lipid peroxidation products (17),
homocysteine (18), 8–hydroxy-2’-deoxyguanosine in urine
(19) and interleukin 10 or TNF-alpha in exhaled air (20),
have been reported. Higher-than-normal levels of plasma
homocysteine, which is an indirect marker of oxidative
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stress, have been detected in OSA patients (21). Christou
et al. provided further evidence showing that patients with
severe OSA have a reduced antioxidant capacity (22). Other
studies have indicated that continuous positive airway
pressure (CPAP) therapy diminishes plasma oxidative stress
(23,24). However, few studies have examined a wider array of
antioxidant biomarkers as surrogate measures of oxidative
stress in OSA patients.
Preliminary evidence indicates that folic acid and vitamin
B12 have anti-apoptotic efficacy and the ability to preserve
mitochondrial function (25). Furthermore, vitamin B11
deficiency has been associated with elevated concentrations
of homocysteine in the plasma of elderly non-demented
patients (26,27). High vitamin B11 (plasma folate) con-
centrations have been associated with improved global
cognitive function (26). However, the association between
homocysteinemia and decreased cognition was only ob-
served in participants with low folate levels (28), which
suggests potential interplay between these factors. Re-
cently, Singh et al. (2009) determined that both CPAP
treatment and antioxidant treatment (oral vitamin E and C)
reduced oxidative stress in OSA patients (29). Despite these
findings, a relationship between antioxidant biomarkers
and cognitive impairment has not been established in OSA
patients.
The aim of this studywas to investigate neuropsychological
performance and oxidative stress biomarkers in OSA patients
and to evaluate the relationship between these factors.
& MATERIAL AND METHODS
Study Design and Subjects
All of the subjects were clinically evaluated, underwent
neuropsychological tests and polysomnography and had
blood samples taken in the morning. The study was
approved by the Ethics Committee for Research of the
Hospital Sa˜o Paulo-UNIFESP (# CEP 1266/03), and all of
the participants provided written informed consent.
The male patients were consecutively recruited at the
Sleep Institute of Sa˜o Paulo. The inclusion criteria included
an age between 25 to 65 years, a body mass index (BMI),40
and a minimum of 11 years of formal education. All of the
cases had confirmed clinical and polysomnographic diag-
noses of OSA: apnea-hypopnea index (AHI) above 10
events/h (rather than 5) and at least one symptom or AHI
above 15. The exclusion criteria included previous CPAP
therapy, the presence of shift work, severe depression,
endocrinopathies, (including dyslipidemia, diabetes, obesity
or metabolic syndrome), arterial hypertension, anemia,
AIDS, current acute myocardial failure or arrhythmia,
history of neoplasia, and neurologic or psychiatric disease
(including substance/alcohol abuse), as well as the use of
hypnotics, neuroleptics, beta-blockers, anti-epileptics, anti-
rheumatic medication, steroids and non-steroid anti-inflam-
matory drugs (NSAIDs), lipid reducers and vitamins. The
control group was recruited from the relatives of patients
and the employees of the Sleep Institute. The control sub-
jects were matched according to age, sex, weight, scores on
the Beck Depression Inventory (30) and years of education,
and they were subject to the same inclusion and exclusion
criteria as patients, except that they had no sleep disorders
(confirmed by polysomnography).
Clinical Assessment. Examination includedmeasurement
of weight, height and blood pressure; ectoscopy; neurological
examination; ear, nose and throat exam; electrocardiography
(ECG) and polysomnography. Sleep complaints were eva-
luated using a questionnaire that had been adapted for local
use, daytime sleepiness was evaluated using the Epworth
Sleepiness Scale (ESS) (36) and depressive symptoms were
evaluated using the Beck Depression Inventory (30,31). The
neuropsychological test battery included measures of various
different cognitive functions. Blood samples were collected to
assay oxidative stress biomarkers.
Polysomnography
The recorded parameters included the following: electro-
encephalogram, electrooculogram, electromyogram (submen-
tonian region and tibialis anterior muscle), electrocardiogram,
air flow (recorded by a nasal pressure cannula and a buccal
thermistor), respiratory effort by abdominal and thoracic
movement (inductance plethysmography), body position,
oximetry and snoring (Sonolab MeditronH). The sleep stage
scoring (32), respiratory patterns (1), arousals (33) and
periodic leg movements were analyzed according to inter-
national criteria (34).
Neuropsychological Tests
Classical psychometric tests adapted for local use were
selected to assess attention, various subcomponents of work-
ing memory (including executive functions) and episodic
memory. Testing was carried out at approximately 10:00 AM
during two sessions that lasted approximately 45 minutes
each. The neuropsychological measures were investigated
using the Toulouse-Pie´ron Attention Test (35,36), the
Wisconsin Card Sorting Test (WCST) for executive functions
(37,38), the Digit Symbol Substitution Test (39) for the
processing of visual figures, the forward Digit Span mea-
suring the functioning of phonological storage within work-
ing memory and the backward Digit Span evaluating
executive functions. Other tests included the Similarities Test
to evaluate abstract verbal reasoning, the Logical Memory and
Verbal Paired Association Tests to evaluate episodic memory
(immediate recall short-term verbal memory) and long-term
memory (delayed recall long-term verbal memory) (13), and
the immediate and delayed recall of the Rey-Osterrieth
Complex Figure Test (40,41) to evaluate short- and long-term
visual non-verbal memory, respectively, as well as planning
and perceptual organization.
Biomarkers of Oxidative Stress
For the biochemical analyses, venous blood was collected
in the morning, at approximately 8:00 AM after 12 hours of
fasting. The red blood cells were washed and hemolyzed to
assay the antioxidant enzymes and glutathione, whereas the
plasma was used for the vitamin and amino acid assays.
Two enzymatic antioxidants were assayed, i.e., superoxide
dismutase (SOD) (42) and catalase (43), in addition to three
other non-enzymatic antioxidants, i.e., glutathione (44) and
vitamins B11 and B12 (45).
Statistical Analysis
Descriptive statistics are presented as the mean¡stan-
dard deviation, range and frequency (% values). Fisher
exact tests for categorical variables, the Mann-Whitney U
test for continuous variables and Student’s t test for normally
distributed data with equal variances were performed to
compare the cases and controls. Linear regression analysis
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was used to examine the relationship between scores of
neuropsychological tests (dependent variables) and the levels
of biomarkers for oxidative stress. Posterior adjustments for
age and BMI were performed. The level of significance was
set at p,0.05. Analyses were conducted using the Statistical
Package for Social Sciences V16.0 [SPSS Inc., Chicago, IL,
USA].
& RESULTS
In total, 32 out of 63 consecutively evaluated OSA patients
from an outpatient sleep disorder clinic met the inclusion
requirements. Of these 32 patients, 18 were initially
recruited; the remaining 14 cases were excluded because
the presence of shift work (N=4), the use of medication
(NSAIDs and vitamins, N= 1), the presence of arterial
hypertension (N=1), high scores on the Beck Depression
Inventory (N= 5), refusal of neuropsychological testing
(N= 3) or refusal to participate without a specific reason
(N=4). Fourteen patients who met the eligibility require-
ments and 13 controls were studied. Thirteen controls were
included. The cases and controls were similar with regard to
years of schooling (.11 years), age (p= 0.62) and BMI
(p= 0.12). As expected, the OSA patients presented more
sleep complaints (UNIFESP sleep questionnaire) than the
controls (p,0.001) and more daytime sleepiness (ESS,
p,0.001). Excessive daytime sleepiness (ESS.10) was more
frequent in the OSA patients than in the controls (78.6% vs
15.4%; p= 0.001). Depressive symptoms (according to the
BDI) were similar between the cases and controls (p=0.08).
By definition, the cases presented higher values of AHI
than the controls (p,0.001), as well as lower minimum
oxygen saturation levels (SpO2 minimum) (p= 0.003) and an
increased micro arousal index (p= 0.006) (Table 1).
Neuropsychological Tests
The patients performed worse in the classical attention
test (Toulouse-Pie´ron), with significantly more errors
(p,0.02). Working memory was also significantly impaired
in the patients with regard to retention of the episodic buffer
(Logical Memory A+B immediate recollection, p,0.04; Rey
Immediate Recall, p,0.001) and executive measures (back-
ward digit span, p= 0.006; similarities, p,0.005; persevera-
tion errors in the WCST, p,0.04).
The patients also showed worse verbal memory perfor-
mance according to the Logical Memory Delayed Recollec-
tion (A+B, p,0.05) and the verbal paired associates delayed
recollection (easy plus difficult, p,0.02). Furthermore,
reduced values were observed on the Rey Figure Delayed
Recall, which is a long-term non-verbal memory test (p,0.001)
(Table 2).
Antioxidant and Pro-Oxidative Stress Markers in Patients
and Controls. The patients presented lower levels of vita-
min E (p,0.006), SOD (p,0.001) and vitamin B11 (p,0.001),
as well as higher levels of homocysteine (p,0.02). Serum
concentrations of vitamin C, catalase, glutathione and vi-
tamin B12 were equivalent and within the normal range
(Table 3).
Correlations between Oxidative Stress Markers and
Neuropsychological Test Scores. Comparisons between
levels of oxidative stress markers and neuropsychological
results revealed a correlation between serum concentrations
of vitamin E and the results of the backward digit span task
(r = 0.76; p= 0.002) in the OSA patients (Figure 1); a similar
Table 1 - Polysomnographic results (mean¡SD) in
controls and patients with obstructive sleep apnea.
Controls
(N=13)
Patients
(N=14) p-value
Clinical data and questionnaires
Age (years) 36.0¡6.1 37.2¡6.9 0.61
Body mass index
(Kg/m2)
26.9¡2.9 28.8¡3.3 0.13
BDI scores 0.9¡1.7 2.4¡2.5 0.08
ESS scores 1.4¡0.5 9.6¡6.1 ,0.005**
Polysomnography measures
Sleep efficiency 87.3¡8.2 87.8¡8* 0.89
S1 (%TTS) 3.2¡1.6 6.6¡5.1*
S2 (%TTS) 59.3¡6.5 63.8¡11.3*
S3 (%TTS) 15.1¡4.5 11.3¡7.3*
REM (%TTS) 22.4¡3.3 18.3¡8.6*
Arousals/h 7.7¡3.4 37.9¡36.9 ** ,0.005**
AHI 1.9¡1.5 36.4¡28.8 **
Minimum SpO2 (%) 88.8¡2.6 78.0¡11.9 **
Student’s t test *p,0.05; ** p,0.01.
Table 2 - Neuropsychological test results (mean¡SEM) in the controls and patients with obstructive sleep apnea.
Neuropsychological Tests Controls (N=13) Patients (N =14) p-value
Toulouse-Pie´ron Correct Answers 161.6¡40.7 132.8¡29.2 0.05
Toulouse-Pie´ron Errors 0.07¡0.3 0.68¡0.7 0.01*
Digit Symbol 55.53¡13.1 51.7¡12.7 0.44
Forward Digit Span 5.85¡1.1 5.8¡0.7 0.97
Backward Digit Span 5.15¡0.9 4.07¡1.0 0.006
Similarities 24.77¡1.6 21.0¡4.0 0.004**
Logical Memory–R I (A+B) 32.54¡4.7 27.2¡7.1 0.03*
Logic Memory–R T (A+B) 29.92¡4.2 25.0¡7.1 0.04*
Verbal PA–1st Trial 5.07¡1.7 4.5¡1.5 0.36
Verbal PA–2nd Trial 6.4¡1.5 6.1¡1.4 0.56
Verbal PA–3rd Trial 7.3¡0.8 6.7¡1 0.12
Verbal Recollection P A 7.3¡0.8 5.7¡1.5 0.001**
Rey Figure–Copy 34.4¡1.8 33.7¡2.6 0.39
Rey Figure-R I 29.5¡2.9 24.0¡4.2 ,0.001**
Rey Figure-R T 29.7¡3.6 22.3¡5.4 ,0.001**
Perseverative Errors 2.2¡5.1 6.07¡3.8 0.03
Failure in Keeping the Set 0.41¡0.9 2.1¡3.3 0.09
PA=Paired-Associated; IR = Immediate Recall; LR= Late Recall. Mann-Whitney Test *p,0.05 **p,0.01.
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correlation was not observed in the controls (r = 0.23;
p= 0.43). A correlation was observed between the SOD
concentration and the executive non-perseveration errors on
the WCST in the OSA patients (r = 0.63; p= 0.01) (Figure 2);
a similar correlation was not observed in the controls
(r = -0.44; p= 0.10). The correlation between vitamin E levels
and the backward digit span task remained after controlling
for age and BMI (r = 0.69; p= 0.009), as did the correlation
between SOD levels and WCST scores (r = 0.63, p= 0.02). No
correlations were found among the other oxidative stress
parameters, the neuropsychological results and the poly-
somnographic variables in the OSA patients and in the
controls.
& DISCUSSION
The present study, which evaluated a wide range of
oxidative stress biomarkers, confirms that oxidative stress is
critically elevated in OSA patients. The present study also
substantiates an important role for vitamin E and SOD, as it
demonstrates a relationship between these antioxidants and
neuropsychological performance. It should be noted that the
association between OSA and cognitive impairment is
complicated by numerous comorbidities, including aging,
obesity, genetic factors, hypoxemia, daytime somnolence,
cerebrovascular disease and endothelial dysfunction (7). To
address this issue, this study considered matched groups of
patients and controls, so that the only difference across the
groups was a high or low apnea index. It should also
be noted that the present study did not find a correlation
between neuropsychological results and polysomnographic
measures, including oxygen desaturation and/or sleep
fragmentation.
To date, various cognitive deficits have been identified in
OSA patients. Deficits in attention, vigilance, memory and
executive function have all been described. Attempts to
explain these alterations have been made using both animal
models and patients with OSA. Gozal et al. studied young
adult rats and examined the effects of fluctuating ambient
oxygenation on learning and neuronal health (46). Based on
their results, a model was proposed for a conceptual frame-
work. In this model, sleep fragmentation and/or intermittent
hypoxemia and hypercarbia disrupt the restorative fea-
tures of sleep and consequently disrupt cellular or chemical
homeostasis (47). All of these disturbances induce cellular
and biochemical stress. Oxidative stress (48), apoptosis-
related neural injury, reduced expression of brain-derived
neurotrophic factor (BDNF) (49) and molecular alterations
(50) have been described in association with neural injury in
OSA (51). Consequently, alterations of the cerebral cortex,
particularly the pre-frontal cortex, and cognitive dysfunction
occur. Neuroimaging studies have confirmed the involve-
ment of the pre-frontal cortex in OSA (52). These alterations
have been shown to improve with treatment (53). In addition,
recent studies showed that young children with sleep apnea
may also undergo neuronal loss and cognitive impairments
(54).
Controversy remains regarding the role of hypoxia in
cerebral changes related to OSA. For example, most animal
models have used fluctuating ambient oxygen patterns to
reproduce the chronic intermittent hypoxia associated with
OSA. Therefore, the observed brain alterations could merely
be secondary to cerebral hypoxia. In contrast to this expla-
nation, sleep fragmentation was recently shown to have an
impact on both brain-specific alterations and general meta-
bolism (55). Furthermore, Thomas et al. examined OSA
patients using functional magnetic resonance imaging and
demonstrated a lower level of activation of the prefrontal
Table 3 - Oxidative stress parameters (mean¡SD) in the
controls and patients with obstructive sleep apnea.
Oxidative stress parameters
Controls
(N=13)
Patients
(N=14) p-value
Non-enzymatic antioxidant markers
Vitamin E mmol/L 19.1¡6.7 12.8¡3.6 0.005**
Vitamin C mmol/L 46.7¡14.5 49.2¡12.7 0.63
Glutathione mmol/g Hb 7.8¡1.7 7.3¡3.8 0.70
Enzymatic antioxidant markers
SOD U/mgHb 14.4¡2.3 10¡2.9 ,0.001**
Catalase U/mgHb 11¡40 99¡26 0.90
Homocysteine and related vitamins
Homocysteine u/M 10.7¡2.9 16.7¡8.0 0.02*
Vitamin B11 ng/ml 9.3¡2.8 4.8¡2.3 ,0.001**
480¡111 464¡184 0.79
SOD= superoxide dismutase. Student’s t test *p#0.05 **p,0.01.
Figure 1 - Serum concentrations of vitamin E are positively
correlated with backward digit span task results in obstructive
sleep apnea patients (r = 0.75, p=0.002).
Figure 2 - Superoxide dismutase concentrations are positively
correlated with nonperseverative errors in the Wisconsin Card
Sorting Test in obstructive sleep apnea patients (r = 0.63, p=0.01).
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cortex while performing a working memory task that was
similar in hypoxic and nonhypoxic subjects, which indicates
that hypoxia does not influence the cortical dysfunction
observed in sleep apnea (56).
Previous studies of the effects of vitamin E on cognition
and the role of inflammation and oxidative stress in OSA are
controversial. Recently, an uncontrolled study of 20 patients
receiving CPAP therapy found that antioxidant intake
improved the quality of sleep (29). In addition, CPAP has
been reported to improve airway inflammation and oxida-
tive stress (57). Dietary intake of v-3 PUFA has been
associated with lower plasma levels of Ab42, and this
pattern has also been linked with a reduced risk of incident
Alzheimer’s disease and slower cognitive decline (58). In
contradiction to these findings, a metanalysis has shown a
lack of evidence for the efficacy of vitamin E in the
prevention or treatment of dementia (59). Similar to our
findings, increased oxidative stress in the hippocampus and
cognitive impairment were previously associated with sleep
deprivation and the Western diet (60), which indicates that
oxidative stress may present an additional risk factor for the
complex cognitive impairment in OSA.
It should be noted that despite the obvious relationship
between neuropsychological testing and cognitive function,
neuropsychological evaluations describe performance that
is not necessarily related to reduced cognition or dementia.
In other words, neuropsychological tests should be con-
sidered to reflect a cerebral functional state rather than an
established brain alteration. As an example of intermittent
alterations, studies of seals have recently demonstrated
increased levels of endogenous antioxidants to counteract
noxious intermittent hypoxemia and chronic cycles of
ischemia/reperfusion (61). OSA patients are continuously
exposed to intermittent hypoxemia and chronic cycles of
ischemia/reperfusion. Thus, it is possible that the adaptive
mechanisms observed in seals are species-specific. Other
studies may help to corroborate these findings.
This study confirms previous data showing compromised
performance in specific neuropsychological tests, particu-
larly in tests measuring attention and memory. Most of
previous studies did not examine a wide range of
neuropsychological tests. It has recently been noted that
relatively little research has specifically examined the
influence of OSA on intellectual function (3). Furthermore,
in the present study, subjective somnolence was observed in
85% of patients, which agrees with previous studies
estimating that 80% of OSA patients present excessive
daytime somnolence or some other cognitive alteration (62).
Regarding simple attention, a higher number of errors was
observed in the Toulouse-Pie´ron test, which supports a
previous report of a significant reduction in attention on
various tests (63). Detrimental effects were also observed in
episodic and working memory, which corroborates pre-
vious findings that these cognitive domains are impaired in
OSA patients (64).
With regard to oxidative stress markers, a reduction in the
blood concentration of vitamin E was observed, which
agrees with the findings in a previous report (65). With
regard to enzymatic antioxidants, the OSA patients exhib-
ited a decrease in SOD, which is the first enzyme of the
antioxidizing pathway and may represent an oxidant signal.
A previous study showed that fMLP-stimulated superoxide
release was markedly increased in OSA patients when
compared to a control group (66). However, another study
found that SOD concentrations were within normal levels in
these patients (67). These discrepancies in SOD findings
may be the result of methodological differences. Although
the current study measured SOD values in erythrocytes,
Schulz et al. (2000) analyzed neutrophils (66). Furthermore,
other factors (such as age) are known to influence
antioxidant measurements. In this study, we observed an
increase in homocysteine and a reduction of vitamin B11 but
not B12, both of which play fundamental roles in homo-
cysteine metabolism. The vitamin B11 reduction was
accompanied by augmented plasma concentrations of
homocysteine, as expected (28). Our data are in agreement
with another study showing increased homocysteine levels
in OSA patients (68). In the present study, blood was
obtained from individuals in the morning, at a time when
homocysteine concentrations are usually low, and yet
concentrations of homocysteine were elevated beyond the
normal range.
Some limitations to this study must be acknowledged.
This study was an observational cross-sectional evaluation,
and a cause/effect relationship among neuropsychological
dysfunction, vitamin E and SOD cannot be established. The
present evidence is important because it has potential
implications for future therapies; however, these data only
provide initial evidence, and more experiments to assess the
relationship between antioxidants and neuropsychological
tests in OSA patients are warranted. In this study, a wide
sample of neuropsychological tests and several antioxidant
biomarkers was examined. It should be noted that all of the
study subjects were male, and the results may not be
generalized to women. These results are unique and have
not been previously shown. The evidence described here
could be corroborated by prospectively studying the effects
of administering vitamin E and other antioxidants on
neuropsychological test scores in OSA patients.
In conclusion, decreased levels of antioxidants were
observed in OSA patients. This study raises the possibility
that an imbalance between antioxidants and pro-oxidants
may contribute to the neuropsychological alterations
observed in OSA patients. To the best of our knowledge,
this is the first clinical investigation to relate neuropsycho-
logical alterations to oxidative stress biomarkers in OSA.
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